Cadila Healthcare's Q2 net up 33% to Rs 503 cr

During the quarter, the company launched four new products in the US

Zydus Cadilla, healthcare, Sentynl, Ahmedabad

Premium

<b>BUYING SPREE:</b> This is the fifth product and company acquisition by Zydus in 12 months

BS Reporter Ahmedabad

Last Updated : Nov 14 2017 | 9:16 PM IST

Cadila Healthcare Limited, also known as Zydus Cadila, reported a net profit growth of 33 per cent at Rs 503 crore in second quarter ended September 30, 2017, up from roughly Rs 378 crore for the said period last year.

While total income from operations grew by 35 per cent year-on-year in Q2 to stand at Rs 3,234 crore, Cadila Healthcare's business in the US posted sales of Rs 1,644 crore, up by 66 per cent, the company stated in an official communique.

During the quarter, the company launched four new products in the US including Mesalamine Delayed Release 1.2

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in